Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2002

View Archived Issues

Vitamin C conjugates improve entry of CNS drugs into the brain

KB-130015: a potential antiarrhythmic agent with an improved safety profile compared to amiodarone

Millennium reports significant progress during 2001

Signature to acquire PrimeCyte

Enrollment completed in hysterectomy arm of phase II trial in uterine fibroids

Introgen receives grant to evaluate INGN-241 in melanoma

OP-2000 granted new generic name by USAN

Allergan and EntreMed enter five-year strategic alliance in eye diseases

Appetite suppression with C-75 associated with alterations in balance of hypothalamic neuropeptides

Orfadin approved for treatment of hereditary tyrosinemia type I

Altea receives grant for MicroPor delivery of insulin

Phytomedics and Degussa BioActives to codevelop PMI-5011

Modafinil receives approval in Mexico

Progen enrolls first patient in phase II trial of PI-88 in multiple myeloma

Pfizer describes series of hygromycin A derivatives

Lactams that inhibit Abeta formation with potential in Alzheimer's disease

Short-course therapy with Zithromax approved for otitis media

Amino-substituted carbothioic acid esters that act as apoptosis inducers

Chugai discloses new series of vitamin D derivatives and their use

Compounds with thrombopoietin-like activity tested at Chugai

Excitatory amino acid modulators patented by Lilly

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026